Eben Scanlon, Chief Customer Officer at OneStudyTeam
Patient engagement is critical on several levels. It helps inform updates to trial design and processes, it ensures critical data is collected to determine the safety and efficacy…
Continue Reading
What You Should Know:
The funds are crucial for the advancement of Hyivy Health clinical trials and to prepare for market entry. CEO Rachel Bartholomew acknowledges fundraising challenges in the femtech space. “Fundraising in the…
Continue Reading
What You Should Know:
– Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Patient Payments, a new solution that streamlines trial-related…
Continue Reading
What You Should Know:
– OneStudyTeam, a member of the Reify Health portfolio, provides the cloud-based software platform StudyTeam to accelerate the development of new and life-saving therapies. StudyTeam brings research site workflows online and enables…
Continue Reading
The following is a guest article by Jay Nakashima, President at eHealth Exchange
An FDA project aims to make it as easy as possible for clinicians to report adverse drug events and share important clinical…
Accelerating clinical evidence generation is one of the most important steps the healthcare industry can take to advance personalized treatment, Amy Abernethy declared in an interview this week.
“When I talk about clinical evidence generation,…
Continue Reading
What You Should Know:
– Sheba Medical Center, Israel’s largest hospital, and ARC Innovation, the innovation arm of Sheba, has announced a strategic partnership with Paradigm Health to establish a global network for clinical research.
–…
Continue Reading
Shelli Pavone, CEO & President, Inlightened
Last month was Cancer Research Awareness Month, which is a great time to celebrate recent findings that the number of adults enrolled in oncology clinical trials has increased –…
Continue Reading
What You Should Know:
– Florida Cancer Specialists & Research Institute (FCS), a leading provider of comprehensive cancer care, has announced a new partnership with Paradigm Health, a technology platform specializing in clinical trial management.
–…
Continue Reading
What You Should Know:
– Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN), a clinical-stage biotechnology company focused on developing organ regeneration technology for severe diseases, has secured approximately $5 million from a new investor through…
Continue Reading
